Xconomy Boston’s Top Stories of Q2 2014: Editor’s Picks
Here are my picks for our top local stories of the past quarter (April-June), and why.
Not a ranked list, just in reverse chronological order:
Could something as boring as insurance derail Uber?
Cutting-edge genomics company, meet veteran exec.
Series A crunch? Not so much, if you read this list of deals.
Obesity and weight loss continues to be a huge market for drugmakers.
One of the biggest biotech startups, now doing its own startups.
Attempted murder, shootings, bankruptcy… not your average VC/startup story.
Education tech hasn’t exploded yet, but it’s about to.
This one resonated with entrepreneurs, Springpad users, and anyone interested in why startups fail.
Everyone loves Uber. Everyone except her.
What’s the social network working on locally? Hard tech problems, not surprisingly.
A scoop on the Internet retail giant’s plans in Kendall Square.
Cleantech is on the rise—and here’s one of the hotspots around town.
Near-death company stories are riveting, especially when the company is trying to go public.
In-depth Q&A with one of biotech’s leading figures.
Pretty much boils down to VCs and startups vs. EMC.
Why? Cost and technology problems. Also physician culture and patient privacy.
Very early but promising results for an experimental cancer treatment.
Boston University went and sued Apple, Amazon, and a bunch of tech companies. Here’s how they settled.
Brash biotech looking to revolutionize healthcare. We’ll see.